Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,045 USD | +16,32% | -7,76% | +34,93% |
Omzet 2024 * | 74,35 mln. 69,74 mln. | Omzet 2025 * | 63,82 mln. 59,86 mln. | Marktkapitalisatie | 230 mln. 215 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -102 mln. -95,67 mln. | Nettowinst (verlies) 2025 * | -132 mln. -124 mln. | EV/omzet 2024 * | 3,09 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 3,6 x |
K/w-verhouding 2024 * |
-2,45
x | K/w-verhouding 2025 * |
-1,93
x | Werknemers | 449 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 15,06% |
Recentste transcriptie over Adaptimmune Therapeutics plc
1 dag | +16,87% | ||
1 week | -7,76% | ||
Lopende maand | -32,28% | ||
1 maand | -24,11% | ||
3 maanden | +52,29% | ||
6 maanden | +84,48% | ||
Lopend jaar | +34,93% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 57 | 01-01-08 | |
Adrian Rawcliffe
CEO | Chief Executive Officer | 52 | 01-03-15 |
Gavin Wood
DFI | Director of Finance/CFO | 54 | 01-04-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 01/11 |
Andrew Allen
BRD | Director/Board Member | 57 | 01-06-23 |
David Mott
CHM | Chairman | 58 | 01-09-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 1,07 | +19,10% | 865 523 |
18-04-24 | 0,8984 | -8,98% | 3 345 633 |
17-04-24 | 0,987 | -4,17% | 1 222 265 |
16-04-24 | 1,03 | -1,90% | 1 224 206 |
15-04-24 | 1,05 | -9,48% | 1 324 308 |
uitgestelde koers Nasdaq, 19 april 2024 om 17:49 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,93% | 230 mln. | |
-3,09% | 102 mld. | |
+1,63% | 96,07 mld. | |
-1,80% | 21,66 mld. | |
-17,55% | 20,77 mld. | |
-6,91% | 18,53 mld. | |
-42,00% | 16,91 mld. | |
-27,94% | 13,79 mld. | |
+0,12% | 13,33 mld. | |
+19,76% | 10,94 mld. |